Jeffrey E. Kelsey

Demonstration of the Efficacy and Safety of a Novel Substance P (NK1) Receptor Antagonist in Major Depression

Mark S. Kramer, Andrew Winokur, Jeffrey E. Kelsey et al. · Neuropsychopharmacology · 2003 · 258 citations

Psychiatry, Functional Selectivity, Medicine +14

The Neural Correlates of Social Anxiety Disorder and Response to Pharmacotherapy

Clinton D. Kilts, Jeffrey E. Kelsey, Bettina Knight et al. · Neuropsychopharmacology · 2006 · 131 citations · Full text

Experimental Psychopathology, Psychiatry, Behavioral Neuroscience +15

Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial

Murray B. Stein, Mark H. Pollack, Alexander Bystritsky et al. · Psychopharmacology · 2004 · 109 citations

Psychotherapy, 6-Month Randomized, Psychiatry +9

Removing the superior colliculus silences eye movements normally evoked from stimulation of the parietal and occipital eye fields

E. Gregory Keating, Stephen G. Gooley, Susan E. Pratt et al. · Brain Research · 1983 · 85 citations

Cognitive Science, Blindsight, Ophthalmology +14

Venlafaxine in social phobia.

Jeffrey E. Kelsey · PubMed · 1995 · 83 citations

Psychopathology, Serotonin Reuptake Inhibitors, Psychiatry +14